SEC Form 4 · accession 0001209191-17-046837
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Drake R. Parker
Officer — Chief Business Officer
Period of report
Jul 27, 2017
Accepted (ET)
Jul 31, 2017 · 8:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $27.30 | Jul 27, 2017 | A | 50,000 | A | — | Jul 26, 2027 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The vesting commencement date of the option is July 27, 2017. 25% of the shares subject to the option shall vest on July 27, 2018 and 1/48th of the shares subject to the option shall vest monthly thereafter over three (3) years.